• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病和长QT综合征的DNA检测及级联筛查的障碍:一项关于患者经历的定性研究

Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences.

作者信息

Smart Andrew

机构信息

School of Science, Society and Management, Bath Spa University, Newton Park Campus, Newton St Loe, Bath, UK.

出版信息

J Genet Couns. 2010 Dec;19(6):630-9. doi: 10.1007/s10897-010-9314-0. Epub 2010 Aug 3.

DOI:10.1007/s10897-010-9314-0
PMID:20680418
Abstract

This paper reports data from a qualitative study of patient experiences of DNA testing and cascade screening for hypertrophic cardiomyopathy and long QT syndrome, cardiac conditions that place sufferers at risk of sudden death. The paper particularly focuses on potential impediments to testing and screening. Semi-structured interviews were undertaken with a purposive sample of 27 people in the UK who had undergone testing. In the context of the uncertainties that can characterize experiences of these disorders, the majority of participants in this sample embraced testing and screening as a way of providing health information for themselves or their relatives (particularly children). There was nevertheless evidence of ambivalence about the value and impact of the DNA test information which could influence participants' dispositions toward testing, and play into dilemmas about family communication. Other concerns arose in relation to communicating about these disorders, decisions to involve elderly relatives and pressures relating to family responsibility. The evidence of ambivalence provides insight into why some people may be resistant to testing, screening and sharing information. The findings about communication processes indicate potential areas of concern for the cascading process.

摘要

本文报告了一项定性研究的数据,该研究针对肥厚型心肌病和长QT综合征患者的DNA检测及级联筛查经历展开,这两种心脏疾病会使患者面临猝死风险。本文特别关注检测和筛查的潜在障碍。对英国27名接受过检测的人进行了有目的抽样的半结构化访谈。在这些疾病经历可能具有的不确定性背景下,该样本中的大多数参与者接受检测和筛查,将其视为为自己或亲属(尤其是孩子)提供健康信息的一种方式。然而,有证据表明,对于DNA检测信息的价值和影响存在矛盾态度,这可能会影响参与者对检测的倾向,并引发家庭沟通方面的困境。在关于这些疾病的沟通、让老年亲属参与的决定以及与家庭责任相关的压力方面,也出现了其他问题。这种矛盾态度的证据有助于理解为什么有些人可能会抵制检测、筛查和信息共享。关于沟通流程的研究结果指出了级联过程中可能令人担忧的潜在领域。

相似文献

1
Impediments to DNA testing and cascade screening for hypertrophic cardiomyopathy and Long QT syndrome: a qualitative study of patient experiences.肥厚型心肌病和长QT综合征的DNA检测及级联筛查的障碍:一项关于患者经历的定性研究
J Genet Couns. 2010 Dec;19(6):630-9. doi: 10.1007/s10897-010-9314-0. Epub 2010 Aug 3.
2
Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy.儿科长 QT 综合征和肥厚型心肌病的基因检测和级联筛查。
Heart Rhythm. 2020 Jan;17(1):106-112. doi: 10.1016/j.hrthm.2019.06.015. Epub 2019 Jun 20.
3
Role of DNA testing for diagnosis, management, and genetic screening in long QT syndrome, hypertrophic cardiomyopathy, and Marfan syndrome.DNA检测在长QT综合征、肥厚型心肌病和马凡综合征的诊断、管理及基因筛查中的作用。
Heart. 2001 Jul;86(1):12-4. doi: 10.1136/heart.86.1.12.
4
Genetic testing for risk stratification in hypertrophic cardiomyopathy and long QT syndrome: fact or fiction?肥厚型心肌病和长QT综合征风险分层的基因检测:事实还是虚构?
Curr Opin Cardiol. 2005 May;20(3):175-81. doi: 10.1097/01.hco.0000163668.44141.89.
5
[Gene tests in cardiac rhythm disturbances--new international expert recommendations].
Duodecim. 2012;128(7):697-704.
6
Calmodulinopathy Associated Long QT Syndrome, Hypertrophic Cardiomyopathy With Excessive Trabeculation in a 14-Year-Old Girl Presenting With Ventricular Fibrillation.一名14岁患有心室颤动的女孩,其钙调蛋白病相关的长QT综合征、伴有过多肌小梁的肥厚型心肌病
Circ Genom Precis Med. 2024 Feb;17(1):e004163. doi: 10.1161/CIRCGEN.123.004163. Epub 2024 Jan 23.
7
Yield of molecular and clinical testing for arrhythmia syndromes: report of 15 years' experience.心律失常综合征的分子和临床检测的结果:15 年经验报告。
Circulation. 2013 Oct 1;128(14):1513-21. doi: 10.1161/CIRCULATIONAHA.112.000091. Epub 2013 Aug 20.
8
The phenotype/genotype relation and the current status of genetic screening in hypertrophic cardiomyopathy, Marfan syndrome, and the long QT syndrome.肥厚型心肌病、马凡综合征和长QT综合征的表型/基因型关系及基因筛查现状。
Heart. 1997 Aug;78(2):110-6. doi: 10.1136/hrt.78.2.110.
9
The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.肥厚型心肌病家族筛查的接受情况和促进家庭沟通的在线视频干预措施。
Mol Genet Genomic Med. 2019 Nov;7(11):e940. doi: 10.1002/mgg3.940. Epub 2019 Sep 3.
10
Factors influencing uptake of familial long QT syndrome genetic testing.影响家族性长QT综合征基因检测接受度的因素。
Am J Med Genet A. 2016 Feb;170A(2):418-425. doi: 10.1002/ajmg.a.37455. Epub 2015 Nov 6.

引用本文的文献

1
Evaluation of face validity and core concepts of a novel knowledge scale for inherited heart disease: A pilot study.一种新型遗传性心脏病知识量表的表面效度和核心概念评估:一项试点研究。
J Genet Couns. 2025 Apr;34(2):e1995. doi: 10.1002/jgc4.1995. Epub 2024 Dec 2.
2
Protocol for a type 3 hybrid implementation cluster randomized clinical trial to evaluate the effect of patient and clinician nudges to advance the use of genomic medicine across a diverse health system.一种 3 型混合实施集群随机临床试验的方案,旨在评估患者和临床医生提示在多样化医疗体系中推进基因组医学应用的效果。
Implement Sci. 2024 Aug 19;19(1):61. doi: 10.1186/s13012-024-01385-5.
3

本文引用的文献

1
The genetic basis of long QT and short QT syndromes: a mutation update.长 QT 综合征和短 QT 综合征的遗传学基础:突变更新。
Hum Mutat. 2009 Nov;30(11):1486-511. doi: 10.1002/humu.21106.
2
Depressive symptoms in the congenital long QT syndrome.先天性长 QT 综合征中的抑郁症状。
Ann Med. 2009;41(7):516-21. doi: 10.1080/07853890903037254.
3
Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective.预测性检测肥厚型心肌病突变携带者的遗传咨询与心脏护理:患者视角
Familial communication and cascade testing following elective genomic testing.
选择性基因检测后的家族沟通与级联检测
J Genet Couns. 2025 Feb;34(1):e1907. doi: 10.1002/jgc4.1907. Epub 2024 May 16.
4
Perceived self-efficacy and empowerment in patients at increased risk of sudden cardiac arrest.心脏骤停风险增加患者的自我效能感与赋权感
Front Cardiovasc Med. 2023 May 15;10:955060. doi: 10.3389/fcvm.2023.955060. eCollection 2023.
5
: A qualitative study of psychological sequelae to the implantable cardioverter defibrillator as a treatment for the prevention of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy.一项关于植入式心脏复律除颤器作为致心律失常性右室心肌病心脏性猝死预防治疗手段的心理后遗症的定性研究。
JRSM Cardiovasc Dis. 2017 Mar 8;6:2048004017698614. doi: 10.1177/2048004017698614. eCollection 2017 Jan-Dec.
6
Barriers and facilitators for cascade testing in genetic conditions: a systematic review.遗传疾病级联检测的障碍和促进因素:系统评价。
Eur J Hum Genet. 2020 Dec;28(12):1631-1644. doi: 10.1038/s41431-020-00725-5. Epub 2020 Sep 18.
7
A Person-Centered Approach to Cardiovascular Genetic Testing.以患者为中心的心血管遗传检测方法。
Cold Spring Harb Perspect Med. 2020 Jul 1;10(7):a036624. doi: 10.1101/cshperspect.a036624.
8
The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication.肥厚型心肌病家族筛查的接受情况和促进家庭沟通的在线视频干预措施。
Mol Genet Genomic Med. 2019 Nov;7(11):e940. doi: 10.1002/mgg3.940. Epub 2019 Sep 3.
9
A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.针对遗传性心脏疾病风险亲属的定制告知方法:一项随机对照试验的研究方案。
BMJ Open. 2019 Jul 9;9(7):e025660. doi: 10.1136/bmjopen-2018-025660.
10
Electronic health record access by patients as an indicator of information seeking and sharing for cardiovascular health promotion in social networks: Secondary analysis of a randomized clinical trial.患者获取电子健康记录作为社交网络中促进心血管健康的信息寻求与共享指标:一项随机临床试验的二次分析
Prev Med Rep. 2019 Jan 14;13:306-313. doi: 10.1016/j.pmedr.2018.12.011. eCollection 2019 Mar.
Am J Med Genet A. 2009 Jul;149A(7):1444-51. doi: 10.1002/ajmg.a.32915.
4
Quality of life and psychological distress in hypertrophic cardiomyopathy mutation carriers: a cross-sectional cohort study.肥厚型心肌病突变携带者的生活质量与心理困扰:一项横断面队列研究。
Am J Med Genet A. 2009 Feb 15;149A(4):602-12. doi: 10.1002/ajmg.a.32710.
5
Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death.长QT综合征患者的生活:一项关于应对心脏性猝死风险增加的质性研究。
J Genet Couns. 2008 Oct;17(5):489-98. doi: 10.1007/s10897-008-9167-y. Epub 2008 Aug 22.
6
Congenital long QT syndrome.先天性长QT综合征
Orphanet J Rare Dis. 2008 Jul 7;3:18. doi: 10.1186/1750-1172-3-18.
7
Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy.肥厚型心肌病的遗传咨询与预测性DNA检测的接受情况
Eur J Hum Genet. 2008 Oct;16(10):1201-7. doi: 10.1038/ejhg.2008.92. Epub 2008 May 14.
8
Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy.肥厚型心肌病专科心脏遗传门诊的社会心理影响
Genet Med. 2008 Feb;10(2):117-20. doi: 10.1097/GIM.0b013e3181612cc7.
9
Hypertrophic cardiomyopathy: the genetic determinants of clinical disease expression.肥厚型心肌病:临床疾病表现的遗传决定因素
Nat Clin Pract Cardiovasc Med. 2008 Mar;5(3):158-68. doi: 10.1038/ncpcardio1110. Epub 2008 Jan 29.
10
Psychiatric disorders in hypertrophic cardiomyopathy.肥厚型心肌病中的精神障碍
Gen Hosp Psychiatry. 2008 Jan-Feb;30(1):49-54. doi: 10.1016/j.genhosppsych.2007.09.005.